Top 10 Medical Device Companies to Work For in 2026

A data-driven ranking based on revenue, employee satisfaction, innovation, and career growth

By Olivier Isaac Safir (JD/MBA), CEO of Pact & Partners — 20 years placing executives across 30+ countries in life sciences and medtech

Last updated: March 2026 — Based on Glassdoor, Forbes/Statista 2026, BioSpace, MDDI Top 40, RepVue, and proprietary data from thousands of executive searches across hundreds of life sciences companies

Medical devices is a $650 billion global industry, and it’s growing at roughly 7% a year. That growth is being driven by an aging population, surgical robotics, AI-powered diagnostics, and wearable health monitoring, all of which create career opportunities across engineering, clinical affairs, regulatory, commercial, and leadership roles.

The question isn’t whether medtech is a good career. It is. The question is which companies deliver the best combination of innovation, compensation, and employee experience.

As an executive search firm that has placed thousands of executives across hundreds of life sciences and medtech companies worldwide, Pact & Partners sees which companies candidates fight to join and which ones they try to leave quietly after 18 months. This ranking combines that on-the-ground perspective with data from Glassdoor, Forbes/Statista, MDDI, and RepVue.

How We Built This Ranking

Medtech careers are different from pharma or biotech. Products are hardware, not molecules. The sales cycle involves surgeons, not physicians writing prescriptions. Regulatory paths go through 510(k) or PMA, not NDA. Our criteria reflect what actually matters in this sector:

What We Measured	Weight	Where the Data Comes From
Employer Reputation & Culture	25%	Glassdoor ratings (March 2026), Forbes/Statista Best Large Employers 2026, BioSpace 2026
Revenue Strength & Stability	20%	MDDI Top 40 Medical Device Companies, Getreskilled Top 15, annual reports
Product Innovation & FDA Activity	25%	FDA clearances/approvals 2025-2026, R&D spend as % of revenue, product launches
Global Reach & Career Mobility	15%	Country count, internal transfer programs, P&P placement data across 30+ countries
Compensation & Sales Earning Potential	15%	Glassdoor salary data, RepVue quota and comp data, SEC proxy statements

Companies must be publicly traded (or a division of a public company), generate at least $4 billion in device revenue, and employ at least 5,000 people. We weighted pure-play medtech companies higher than diversified conglomerates, because focused companies tend to offer deeper career tracks in devices.

The Top 10 at a Glance

#	Company	Device Rev.	Glassdoor	Headcount	Core Specialty	2026 Highlight
1	Stryker	$22.6B	4.2/5	~57,000	Ortho, Surgical Robotics	Mako RPS launch, Forbes Best
2	Medtronic	$33.5B	3.8/5	~96,000	Cardio, Neuro, Diabetes	Forbes 2026, MiniMed IPO
3	Boston Scientific	$16.7B	4.0/5	~50,000	Cardio, Endoscopy, EP	Farapoint PFA FDA cleared
4	J&J MedTech	$31.9B	4.0/5	~140,000*	Surgical, Ortho, Vision	Pure healthcare post-Kenvue
5	Abbott	$28.3B	3.9/5	~115,000	Vascular, Diagnostics, CGM	FreeStyle Libre, Abiomed
6	Intuitive Surgical	$8.4B	4.1/5	~10,000	Robotic Surgery	15M+ da Vinci procedures
7	Siemens Healthineers	$25.7B	3.9/5	~76,000	Imaging, Oncology, Lab	Varian integration complete
8	GE HealthCare	$19.7B	3.9/5	~55,000	Imaging, Ultrasound, AI	Post-spinoff AI momentum
9	Edwards Lifesciences	$6.4B	4.0/5	~20,000	Structural Heart (TAVR)	SAPIEN leadership, TMTT
10	Zimmer Biomet	$7.5B	3.6/5	~18,000	Ortho, Sports Med	ROSA robotics expansion

*J&J total across pharma + medtech. Revenue from Getreskilled and MDDI. Glassdoor as of March 2026.

1. Stryker

The company that somehow stays entrepreneurial at $22 billion

Stryker is the medtech company that other medtech companies study when they want to understand how to maintain a performance culture at scale. With $22.6 billion in revenue and roughly 57,000 people, it competes across orthopedics, surgical robotics (Mako), neurovascular, and hospital infrastructure.

In 2026, Stryker announced a limited market release of Mako RPS — a handheld robotic system for total knee replacement that combines robotic guidance with a surgeon-controlled power tool. This is the kind of product development that keeps Stryker on the frontier.

On Glassdoor, the company holds a 4.2/5 rating across 20,000+ reviews. Career mobility scores 4.3/5 and compensation 4.4/5. Forbes/Statista named it among the best medtech employers for 2026. Sales reps report average total comp around $145,000 on RepVue.

One thing that distinguishes Stryker in our recruiting work: they promote aggressively from within, often putting high performers into management within 3-5 years. That creates a young, hungry leadership culture — which attracts ambitious people but can frustrate those who prefer more seasoned managers.

2. Medtronic

The largest pure-play medtech company — with everything that implies

Medtronic leads the industry at $33.5 billion in device revenue, with products in virtually every hospital on Earth and roughly 96,000 employees across 150+ countries. Forbes/Statista included it on the Best Large Employers 2026 list. BioSpace put it on its 2026 Best Places to Work list.

On Glassdoor, the rating sits at 3.8/5 across 26,000+ reviews — solid but below Stryker and Boston Scientific. What employees value: the mission, the global footprint, the breadth of products. What they sometimes struggle with: the bureaucracy inherent in an organization this large.

In 2026, Medtronic is pursuing an IPO of its MiniMed diabetes division, signaling a strategic reshaping of the portfolio. Compensation is structured and competitive across all functions.

Medtronic is one of the employers we recruit for most frequently in our medtech executive search practice. Candidates who want stability, global options, and deep specialization keep coming back to it.

3. Boston Scientific

The most aggressive market-share hunter in medtech

Boston Scientific is winning. The company has been systematically taking share from Medtronic in cardiac and interventional markets, powered by strong products and an explicitly competitive sales culture. Revenue: $16.7 billion across 130 countries with about 50,000 people.

In 2026, its Farapoint pulsed field ablation catheter received FDA clearance for atrial fibrillation — a single device that creates both focal and linear lesions, which is a genuine competitive advantage. Forbes/Statista ranked it among the best medtech employers for 2026.

Glassdoor: 4.0/5 across 16,000+ reviews. Benefits score particularly high at 4.3/5, with employees highlighting 5 weeks PTO and an employee stock purchase plan. RepVue data shows 68% quota attainment across the sales force — a healthy number that suggests achievable targets.

This is a company where performance gets rewarded and coasting gets noticed. In our experience, Boston Scientific reps who hit their numbers make serious money — comfortably above $200,000 in the right territory. But the pace is relentless.

4. Johnson & Johnson MedTech

The brand that every hospital knows

J&J MedTech generates roughly $31.9 billion across surgical (Ethicon), orthopedics (DePuy Synthes), and vision care. With the Kenvue consumer health spinoff complete, J&J is now a pure healthcare company for the first time — which means resources once split across Band-Aids and baby shampoo are now concentrated on medical innovation.

Glassdoor: 4.0/5 with over 25,000 reviews — one of the highest review volumes of any employer. DEI scores 4.2/5, reflecting the company’s Credo-driven culture. Learning budgets of $20,000 per employee per year. CEO approval at 91%.

J&J is big and can move slowly. Candidates we place there tend to be people who value brand prestige, global rotation opportunities, and long career runways over speed and entrepreneurial energy. That’s a real tradeoff, not a weakness — it depends on what you want.

5. Abbott

The company that buys well and integrates better

Abbott stands out for something most large medtech companies fail at: acquiring innovative companies and actually making the integration work. The Abiomed acquisition brought heart support devices; FreeStyle Libre became the global CGM leader. Total device and diagnostics revenue: roughly $28.3 billion, with about 115,000 employees in 160+ countries.

Glassdoor: 3.9/5 across 12,000+ reviews, with culture scoring 4.0/5 and a strong emphasis on ethics. Abbott moves fast — new hires are expected to contribute immediately, and the pace of acquisition means the organization is constantly evolving.

Abbott’s diagnostics and digital health work connects closely to the healthcare technology sector where we also place leadership talent.

6. Intuitive Surgical

The surgical robotics monopoly — for now

Intuitive has enabled over 15 million procedures through da Vinci, creating an installed base and surgeon training ecosystem that competitors struggle to crack. Revenue: $8.4 billion, with roughly 10,000 employees and $1.4 billion in annual R&D spend.

Glassdoor: 4.1/5 with about 3,500 reviews. CEO Gary Guthart has 92% approval. Engineering base salaries start around $140,000+ with significant stock upside. The company is investing heavily in AI-powered surgical guidance.

The assessment: Intuitive’s dominance means sales roles are increasingly about managing installed bases rather than winning new system sales. Engineers love it. Sales hunters may find it limiting. But the compensation and stability are hard to argue with.

7. Siemens Healthineers

Europe’s largest medtech company, with global ambitions to match

Siemens Healthineers brings in roughly $25.7 billion in revenue with 76,000 people — the largest European-headquartered medtech company. Its portfolio spans diagnostic imaging, lab diagnostics, and advanced therapies, significantly strengthened by the $16.4 billion Varian acquisition that added radiation oncology.

Glassdoor: 3.9/5 across about 15,000 reviews. Internal mobility programs score 4.2/5 — the company actively supports cross-continent transfers, which is valuable for anyone building an international career. CEO Bernd Montag has 88% approval.

The culture is more hierarchical than US-based medtechs, but also more stable and predictable. If you want a long, structured international career in imaging or oncology, Siemens Healthineers is one of very few companies that can deliver it.

8. GE HealthCare

Finding its identity after the GE breakup — and investing heavily in AI

Since spinning off from General Electric in January 2023, GE HealthCare has been building its independent identity. Revenue: $19.7 billion, with roughly 55,000 employees. The company is one of the world’s leading providers of medical imaging, ultrasound, and monitoring systems.

Glassdoor: 3.9/5 across about 13,000 reviews. Work-life balance scores a strong 4.1/5, with employees highlighting flexible hours and solid parental leave. CEO Peter Arduini has 86% approval.

GE HealthCare is betting big on AI — partnerships for AI-assisted radiology and clinical decision support are central to the strategy. That creates real opportunities for data scientists and software engineers alongside traditional imaging roles. The tradeoff: some legacy GE processes are still being shed. But that also means you can shape the culture if you arrive now.

9. Edwards Lifesciences

The structural heart specialist where mission isn’t a slogan

Edwards owns the transcatheter aortic valve replacement (TAVR) market through its SAPIEN platform, turning what used to require open-heart surgery into a catheter-based procedure. Revenue: roughly $6.4 billion, with about 20,000 employees.

Glassdoor: 4.0/5 across about 4,000 reviews. Culture scores 4.1/5 — employees consistently mention the patient-focused culture as genuine, not performative. CEO Michael Mussallem has 90% approval. The company offers wellness sabbaticals and hybrid work.

Edwards’ narrow focus is both its strength and its limitation. Career breadth is limited compared to a Medtronic or J&J. But depth is unmatched. If structural heart is your field, there is no better employer anywhere.

10. Zimmer Biomet

The orthopedic incumbent betting on robotics to stay relevant

Zimmer Biomet has dominated orthopedic joint replacement for decades. Walk into most operating rooms and you’ll find Zimmer implants. Revenue: roughly $7.5 billion, with about 18,000 employees. The core hip and knee business is highly profitable, with surgeon loyalty that competitors spend millions trying to build.

Glassdoor: 3.6/5 across about 5,000 reviews — the lowest on this list, reflecting a period of strategic transition. The company is investing heavily in its ROSA robotic platform to compete with Stryker’s Mako, while expanding into sports medicine and trauma.

Forbes/Statista and the MDLiaison medtech analysis both include Zimmer as a consensus top-10 employer. The compensation structure is competitive, with strong commission for orthopedic sales and established territory protection.

Many orthopedic professionals also explore opportunities in the veterinary and animal health sector, where orthopedic device expertise is increasingly valued.

Honorable Mentions

Company	Revenue	Why Notable	2026 Highlight
Hologic	$4.0B	Women’s health specialist. Glassdoor 3.8/5, inclusive culture.	Breast imaging + GYN leadership
Becton Dickinson	$21.7B	Medical supplies, devices, diagnostics. Massive global footprint.	Forbes 2026 Best Employer
Danaher	$9.8B*	Life sciences + diagnostics. Famous for the Danaher Business System.	Lean operations excellence
Philips	$16.1B	Patient monitoring, image-guided therapy. Strong European presence.	Focused portfolio post-restructuring
Smith+Nephew	$5.6B	Ortho, sports medicine, wound care. UK-based with robotics investment.	Digital surgery expansion

*Danaher diagnostics/life sciences portion post-Veralto spinoff.

See also: Top 10 Biotech Companies to Work For in 2026

Why Medtech Careers Keep Getting Better

The US Bureau of Labor Statistics projects medical equipment manufacturing employment growing from roughly 330,000 to 345,500 workers over the coming years. Surgical robotics, AI diagnostics, and wearable monitoring are creating entirely new categories of roles that didn’t exist five years ago.

Compensation reflects the demand. Sales reps at top companies routinely earn $150,000-$300,000+ in the right territories. Engineers, regulatory specialists, and clinical professionals commonly earn $100,000-$180,000 at mid-career. Director and VP roles frequently exceed $250,000.

And there’s something medtech offers that most industries don’t: you can see the direct impact of your work. When a surgeon uses a device you helped develop or sell, and a patient walks out of the hospital healthier — that connection between work and outcome is real.

About the Author

Olivier Isaac Safir (JD/MBA) is CEO of Pact & Partners, a boutique executive search firm that has placed thousands of executives across hundreds of companies in the life sciences, biotech, medtech, and healthcare sectors. With 20 years of experience recruiting across 30+ countries, Olivier brings a data-driven, practitioner perspective to medtech employer analysis.

Olivier Isaac Safir (JD/MBA), CEO
Pact and Partners LLC
pactandpartners.com — linkedin.com/in/oliviersafir

Related Resources from Pact & Partners

• Top 10 Biotech Companies to Work For in 2026 — Companion ranking for biotech
• Top 10 Pharmaceutical Companies to Work For in 2026 — Companion ranking for pharma
• Our Medtech & Life Sciences Executive Search Practice
• Healthcare Technology & Digital Health Recruitment
• Animal Health & Veterinary Executive Recruitment